Equities

Toho Holdings Co Ltd

Toho Holdings Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)3,761.00
  • Today's Change41.00 / 1.10%
  • Shares traded80.40k
  • 1 Year change+41.87%
  • Beta0.2008
Data delayed at least 20 minutes, as of Apr 25 2024 04:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.

  • Revenue in JPY (TTM)1.45tn
  • Net income in JPY17.57bn
  • Incorporated1948
  • Employees7.70k
  • Location
    Toho Holdings Co Ltd5-2-1, DaizawaSETAGAYA-KU 155-8655JapanJPN
  • Phone+81 334197811
  • Fax+81 334146042
  • Websitehttps://www.tohohd.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Selcuk Ecza Deposu Ticaret ve Sanayi AS464.60bn1.06bn163.13bn6.03k153.712.2853.560.35110.35940.3594157.3624.252.3010.7310.4216,218,930.000.52553.161.418.409.389.370.22841.241.05--0.138227.1614.7048.64-64.89-10.6223.1320.11
Guangxi LiuYao Group Co Ltd436.97bn17.11bn166.49bn5.16k9.731.20--0.3812.212.2156.4417.971.027.661.963,961,076.004.365.3711.4512.6611.2611.684.274.481.266.340.564130.4511.1915.0624.4211.81-0.69238.57
DocMorris AG164.61bn-19.96bn195.18bn1.45k--2.29--1.19-10.077.0383.0536.600.986311.3610.50667,214.10-11.96-12.92-15.23-15.7420.9816.84-12.13-10.871.34-2.390.4448--4.13-4.2931.29---2.53--
Sigma Healthcare Ltd343.18bn452.82m214.69bn156.00331.652.3663.560.62560.0040.0043.340.55442.6811.3710.52--0.41620.57340.6250.97629.179.520.15540.20221.861.590.1354184.52-9.16-3.46148.98-34.19-46.55-21.93
Tibet Rhodiola Pharmaceutical Holding Co66.98bn17.12bn253.01bn601.0014.783.54--3.783.233.2312.6413.490.72161.835.715,215,189.0018.6512.4425.2115.7193.8390.5125.8520.432.787.590.129450.4122.6924.98116.5630.01-1.4848.97
GuangYuYuan Chinese Herbal Medicn Co Ltd23.75bn-6.93bn253.15bn1.95k--6.86--10.66-0.6628-0.66282.273.530.40050.80611.31569,846.60-12.26-1.17-16.80-1.6769.2471.94-30.62-3.271.55-18.710.1474--16.44-3.17-26.08---50.29--
Toho Holdings Co Ltd1.45tn17.57bn281.88bn7.70k15.230.962611.640.1944242.08242.0820,008.503,831.191.8114.054.05188,375,100.002.201.836.094.357.948.601.210.97861.05--0.129818.149.672.731.88-1.07-22.491.30
China Medical System Holdings Ltd171.32bn51.33bn344.05bn5.70k6.701.046.162.011.061.063.546.850.45173.426.191,520,575.0013.4418.4415.7021.1476.2475.4729.7634.263.98--0.077240.14-12.438.08-26.335.3538.695.19
China Meheco Group Co Ltd864.91bn12.03bn347.49bn8.31k28.881.45--0.40180.37640.376427.057.481.135.582.764,868,542.002.054.094.449.3711.0715.921.813.381.1621.230.326238.193.754.3713.70-10.9412.63-4.53
Suzuken Co Ltd2.37tn27.68bn355.74bn13.43k13.580.87399.780.150336.97336.9728,802.965,236.471.8212.944.05176,574,900.002.121.776.334.647.758.051.170.91990.9883--0.0031.443.381.7441.351.5717.435.92
Data as of Apr 25 2024. Currency figures normalised to Toho Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

13.15%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 05 Apr 20241.90m2.48%
Nomura Asset Management Co., Ltd.as of 30 Nov 20231.83m2.39%
Norges Bank Investment Managementas of 31 Dec 20231.33m1.74%
Dimensional Fund Advisors LPas of 04 Apr 20241.21m1.58%
Nikko Asset Management Co., Ltd.as of 05 Apr 2024835.90k1.09%
Daiwa Asset Management Co. Ltd.as of 29 Mar 2024817.50k1.07%
BlackRock Fund Advisorsas of 04 Apr 2024812.50k1.06%
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 2024506.00k0.66%
American Century Investment Management, Inc.as of 04 Apr 2024445.40k0.58%
Charles Schwab Investment Management, Inc.as of 04 Apr 2024364.61k0.48%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.